Nitin Mahadev | Vice President, Global Franchise Lead, Rare Disease
Pfizer

Nitin Mahadev has over 25 years of experience and expertise in pharmaceuticals. He currently serves as the Global Gene Therapy and Hemophilia Lead at Pfizer and is responsible for managing a portfolio of in-line hemophilia assets and leading the launch and commercialization of Pfizer’s pipeline in gene therapy and hemophilia. As part of this role, he oversees a global team building the end-end commercial infrastructure for launching gene therapies. Prior to this, Nitin has held several leadership roles at Pfizer across multiple businesses/therapeutic areas and across a wide range of functions including strategy, commercial development and business development. He has also worked as a management consultant advising senior leadership in the major pharmaceutical companies on a wide range of topics. He started his career in R&D as a research scientist. He holds a Bachelor’s in Chemical Engineering from the University of Bombay Institute of Chemical Technology, a Master’s degree in Biochemical Engineering from the University of Maryland Baltimore Country and a MBA from Northwestern University’s Kellogg School of Management.